Trial Profile
A Single Center, Randomized, Single Dose, Open-label, Four Period Cross-over Study to Investigate the Relative Bioavailability of RO4917838 and the Effect of Food Following Oral Administration in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 13 Jun 2016
Price :
$35
*
At a glance
- Drugs Bitopertin (Primary)
- Indications Schizophrenia
- Focus Pharmacokinetics
- Sponsors Roche
- 10 Oct 2012 Actual initiation date changed from Jul 2012 to Aug 2012, as reported by ClinicalTrials.gov.
- 22 Aug 2012 New trial record